COVID-19 Testing Pilot Study

Completed

Conditions studied: Diagnostic Test, Routine, Coronavirus, Diagnoses Disease, Rapid Coronavirus Test

In brief

The purpose of this study is to determine the reliability of a low-cost rapid diagnostic test for COVID-19. The method of the testing procedure uses electrochemistry to detect COVID-19 spike proteins within human samples. To test the effectiveness of this new method, patients will be recruited as they present for testing at ambulatory Penn testing sites. Patients will be asked to self-collect one anterior nares samples under the supervision of authorized study personnel.

Key facts

Study ID

NCT04843878

Run by

University of Pennsylvania

People needed

326

Starts

2021-01-05

Expected to finish

2021-03-12

Last updated by the study team

2021-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The subject must be an adult (age>17) and either sex.
• Written informed consent must be obtained prior to study enrollment.
• a. A subject who is eighteen (18) years or older must be willing to give written informed consent and must agree to comply with study procedures.
• Subject must be able to read and write in English.

You may not qualify if…

• The subject is currently receiving or has received within the past thirty (30) days of the study visit an experimental biologic, drug, or device including either treatment or therapy.
• The subject has previously participated in this research study.

Where it is running

• Penn Presbyterian Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.